Cargando…
A strong case for third-party testing
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Autor principal: | Lund-Johansen, Fridtjof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645416/ https://www.ncbi.nlm.nih.gov/pubmed/37962204 http://dx.doi.org/10.7554/eLife.93329 |
Ejemplares similares
-
Phosphoproteomics of ATR signaling in mouse testes
por: Sims, Jennie R, et al.
Publicado: (2022) -
Association of egg consumption, metabolic markers, and risk of cardiovascular diseases: A nested case-control study
por: Pan, Lang, et al.
Publicado: (2022) -
When is a target not a target?
por: Bersten, David C, et al.
Publicado: (2019) -
Synergy between serum amyloid A and secretory phospholipase A(2)
por: Jayaraman, Shobini, et al.
Publicado: (2019) -
A matter of balance
por: Gitler, Aaron D, et al.
Publicado: (2018)